Introduction 

The Chronic Plaque Psoriasis Market is gaining significant attention in the dermatology sector due to the increasing prevalence of psoriasis worldwide. Chronic plaque psoriasis is the most common form of psoriasis, characterized by red, inflamed patches of skin covered with silvery scales.

This condition is a chronic autoimmune disease that accelerates skin cell production, causing thick, scaly plaques that commonly appear on the elbows, knees, scalp, and lower back.

Although there is no permanent cure, a wide range of treatments are available to control symptoms and improve patients’ quality of life. Continuous innovation in biologic drugs, targeted therapies, and dermatology treatments is driving the expansion of the market in 2026.

Key Market Drivers

Increasing Prevalence of Psoriasis

Psoriasis affects millions of people worldwide. The rising number of diagnosed cases and growing awareness of skin health are contributing to the expansion of the Chronic Plaque Psoriasis Market.

Advances in Biologic Therapies

Biologic drugs have revolutionized psoriasis treatment by targeting specific immune system pathways responsible for inflammation.

Common biologic treatment targets include:

• Tumor Necrosis Factor (TNF) inhibitors
• Interleukin (IL) inhibitors
• Immune system modulators

These therapies provide improved disease control compared to traditional treatments.

Growing Demand for Personalized Dermatology Care

Healthcare providers are increasingly focusing on personalized treatment plans that consider a patient’s disease severity, lifestyle, and response to medications.

Treatment Options in the Chronic Plaque Psoriasis Market

Various treatment approaches are used to manage chronic plaque psoriasis.

Topical Treatments

Topical therapies are often the first line of treatment and include:

• Corticosteroids
• Vitamin D analogues
• Retinoids

These medications help reduce inflammation and slow skin cell growth.

Phototherapy

Phototherapy uses controlled ultraviolet (UV) light exposure to slow excessive skin cell production.

Systemic and Biologic Therapies

Systemic medications and biologics are used for moderate to severe psoriasis cases and target the immune system to reduce inflammation.

Market Segmentation

The Chronic Plaque Psoriasis Market can be segmented based on treatment type, distribution channel, and end users.

By Treatment Type

• Topical therapies
• Phototherapy
• Systemic drugs
• Biologic therapies

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By End User

• Hospitals
• Dermatology clinics
• Specialty healthcare centers

Regional Market Insights

North America

North America dominates the Chronic Plaque Psoriasis Market due to advanced healthcare infrastructure, strong pharmaceutical research, and widespread adoption of biologic therapies.

Europe

Europe is experiencing steady growth supported by increased dermatology research and favorable healthcare policies.

Asia-Pacific

The Asia-Pacific region is expected to witness rapid growth, driven by increasing awareness, improving healthcare infrastructure, and expanding access to dermatology treatments.

Key Companies in the Chronic Plaque Psoriasis Market

Several pharmaceutical companies are actively involved in developing innovative treatments for psoriasis, including:

• Novartis
• Pfizer
• AbbVie
• Amgen
• Johnson & Johnson
• Eli Lilly

These companies are investing in biologic drug development, clinical trials, and strategic collaborations to strengthen their presence in the global market.

Market Challenges

Despite strong growth prospects, the market faces several challenges:

• High cost of biologic therapies
• Limited access to advanced treatments in developing regions
• Long-term treatment adherence issues

Ongoing research and healthcare investments are expected to address these challenges in the coming years.

Emerging Trends in the Chronic Plaque Psoriasis Market

Several innovations are shaping the future of psoriasis treatment:

Next-generation biologic drugs
Targeted immune therapies
AI-based dermatology diagnostics
Personalized medicine approaches

These developments are expected to significantly improve treatment outcomes and patient satisfaction.

Chronic Plaque Psoriasis Market Outlook 2026

The Chronic Plaque Psoriasis Market is expected to grow steadily through 2026 as pharmaceutical companies continue to develop advanced therapies. Increased awareness of autoimmune diseases and expanding dermatology services will further drive market expansion globally.